ReviewCurrent diabetes reports2019
Approaches to Risk Assessment Among Older Patients With Diabetes.
Review in Current diabetes reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed.
- One-year evaluation of a new restorative glass ionomer cement for the restoration of non-carious cervical lesions in patients with systemic diseases: a randomized, clinical trial.Journal of applied oral science : revista FOB · 2020Trial
- 13. Older Adults: Standards of Care in Diabetes-2026.Diabetes care · 2026Review
- A National Physician Survey Examining Switching From Sulfonylureas or Insulin to Newer Diabetes Medications.Clinical diabetes : a publication of the American Diabetes Association · 2025Article
- 13. Older Adults: Standards of Care in Diabetes-2025.Diabetes care · 2025Review
- A National Survey of Physicians' Views on the Importance and Implementation of Deintensifying Diabetes Medications.Journal of general internal medicine · 2024Article
- 13. Older Adults: Standards of Care in Diabetes-2024.Diabetes care · 2024Review
- Diabetes Life Expectancy Prediction Model Inputs and Results From Patient Surveys Compared With Electronic Health Record Abstraction: Survey Study.JMIR aging · 2023Article
- Data-driven classification of health status of older adults with diabetes: The diabetes and aging study.Journal of the American Geriatrics Society · 2023Article
- A National Physician Survey of Deintensifying Diabetes Medications for Older Adults With Type 2 Diabetes.Diabetes care · 2023Article
- A Qualitative Study of Perspectives of Older Adults on Deintensifying Diabetes Medications.Journal of general internal medicine · 2023Article
- 13. Older Adults: Standards of Care in Diabetes-2023.Diabetes care · 2023Review
- Individualized Glycemic Goals for Older Adults Are a Moving Target.Diabetes care · 2022Article
- 13. Older Adults: Standards of Medical Care in Diabetes-2022.Diabetes care · 2022Review
- Reexamining the Classification of Older Adults With Diabetes by Comorbidities and Exploring Relationships With Frailty, Disability, and 5-year Mortality.The journals of gerontology. Series A, Biological sciences and medical sciences · 2021Article
- Improving the American Diabetes Association Framework for individualizing treatment in older adults: evaluating life expectancy.BMJ open diabetes research & care · 2020Article
- Challenges and Strategies for Inpatient Diabetes Management in Older Adults.Diabetes spectrum : a publication of the American Diabetes Association · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
purpose of reviewA patient's prognosis and risk of adverse drug effects are important considerations for individualizing care of older patients with diabetes. This review summarizes the evidence for risk assessment and proposes approaches for clinicians in the context of current clinical guidelines. RECENT
findingsDiabetes guidelines vary in their recommendations for how life expectancy should be estimated and used to inform the selection of glycemic targets. Readily available prognostic tools may improve estimation of life expectancy but require validation among patients with diabetes. Treatment decisions based on prognosis are difficult for clinicians to communicate and for patients to understand. Determining hypoglycemia risk involves assessing major risk factors; models to synthesize these factors have been developed. Applying risk assessment to individualize diabetes care is complex and currently relies heavily on clinician judgment. More research is need to validate structured approaches to risk assessment and determine how to incorporate them into patient-centered diabetes care.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.